Condition
Hematopoietic Stem Cell Transplant (HSCT) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Hematopoietic Stem Cell Transplant (HSCT) clinical trials that are recruiting, at sites in 4 countries (most in United States (3), China (1), India (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Hematopoietic Stem Cell Transplant (HSCT) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Withaferin A to help prevent graft-versus-host disease after stem cell transplant | Phase 1/2 | Navi Mumbai, Maharashtra and 1 other locations | Recruiting | Jul 24, 2026 |
| Venetoclax plus azacitidine consolidation vs standard chemotherapy before stem cell transplant in high-risk AML | Phase 2 | Suzhou, Jiangsu | Recruiting | Feb 23, 2026 |
| Ivosidenib maintenance after allogeneic stem cell transplant for IDH1-mutant AML | Phase 2 | Atlanta, Georgia and 6 other locations | Recruiting | Nov 27, 2024 |
| Collecting data on outcomes of stem cell transplants | — | Hong Kong and 1 other locations | Recruiting | Nov 22, 2024 |
| Treatment for lung infections in patients with certain viral infections and blood cancers | Phase 2 | Duarte, California and 11 other locations | Recruiting | Oct 30, 2024 |
| Long-term observation of lung injury in children after stem cell transplants | — | San Francisco, California and 8 other locations | Recruiting | Sep 23, 2019 |
All recruiting trials (6)
-
Withaferin A to help prevent graft-versus-host disease after stem cell transplant
This trial tests whether adding standardized Withaferin A to standard GvHD prevention can help people 18 and older with blood cancers who are getting a matched related donor stem cell transplant.
-
Venetoclax plus azacitidine consolidation vs standard chemotherapy before stem cell transplant in high-risk AML
This study tests whether a venetoclax-containing consolidation helps newly diagnosed high-risk AML patients who have CR/CRi after VA induction to improve outcomes before allo-HSCT.
-
Ivosidenib maintenance after allogeneic stem cell transplant for IDH1-mutant AML
This trial tests whether taking ivosidenib versus a placebo after allogeneic stem cell transplant can prevent relapse in adults with IDH1-mutant AML.
-
Collecting data on outcomes of stem cell transplants
This study is collecting information from adults who have had stem cell transplants to see what factors affect their recovery and outcomes.
-
Treatment for lung infections in patients with certain viral infections and blood cancers
This study is testing a new inhalation treatment called PUL-042 to see if it can help people with blood cancers or who have had stem cell transplants recover from lung infections caused by certain viruses.
-
Long-term observation of lung injury in children after stem cell transplants
This study looks at children who have had stem cell transplants to see how often they develop lung problems and how these issues affect their health over time.
Related topics
Quick answers
How many Hematopoietic Stem Cell Transplant (HSCT) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), China (1 trial), India (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.